Bone Therapeutics is a leading international biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases. Utilizing the Company's unique knowledge of the bone/joint physiology and long-standing expertise in cell therapy and cell transplantation, Bone Therapeutics has created a fully integrated business with an advanced product pipeline comprising novel bone cell products, tailored in-house production methods, and minimally invasive treatment techniques.
Funding Rounds (1) - $10.36MUpdate
Current Team (1)Update
|May 15, 2015||Business Wire - Bone Therapeutics Provides Business Update for the First Quarter 2015|
|Feb 12, 2015||Fierce Biotech - Bone Therapeutics, Poxel burst out of the gate with oversubscribed IPOs|
|Jan 28, 2013||FinSMEs - FinSMEs|
8 Rue Adrienne Bolland